Medpace Holdings Income After Taxes 2014-2024 | MEDP
Medpace Holdings annual/quarterly income after taxes history and growth rate from 2014 to 2024. Income after taxes can be defined as earnings or losses after income tax expense but before minority interest, extraordinary items, discontinued operations, preferred dividends and accounting changes have been accounted for.
- Medpace Holdings income after taxes for the quarter ending September 30, 2024 was $0.096B, a 36.68% increase year-over-year.
- Medpace Holdings income after taxes for the twelve months ending September 30, 2024 was $0.366B, a 33.85% increase year-over-year.
- Medpace Holdings annual income after taxes for 2023 was $0.283B, a 15.26% increase from 2022.
- Medpace Holdings annual income after taxes for 2022 was $0.245B, a 34.93% increase from 2021.
- Medpace Holdings annual income after taxes for 2021 was $0.182B, a 25.08% increase from 2020.
| Medpace Holdings Annual Income After Taxes (Millions of US $) |
|
|---|---|
| 2023 | $283 |
| 2022 | $245 |
| 2021 | $182 |
| 2020 | $145 |
| 2019 | $100 |
| 2018 | $73 |
| 2017 | $39 |
| 2016 | $13 |
| 2015 | $-9 |
| 2014 | $-16 |
| 2013 | $25 |
| Medpace Holdings Quarterly Income After Taxes (Millions of US $) |
|
|---|---|
| 2024-09-30 | $96 |
| 2024-06-30 | $88 |
| 2024-03-31 | $103 |
| 2023-12-31 | $78 |
| 2023-09-30 | $71 |
| 2023-06-30 | $61 |
| 2023-03-31 | $73 |
| 2022-12-31 | $69 |
| 2022-09-30 | $66 |
| 2022-06-30 | $49 |
| 2022-03-31 | $61 |
| 2021-12-31 | $50 |
| 2021-09-30 | $49 |
| 2021-06-30 | $40 |
| 2021-03-31 | $43 |
| 2020-12-31 | $51 |
| 2020-09-30 | $41 |
| 2020-06-30 | $24 |
| 2020-03-31 | $29 |
| 2019-12-31 | $30 |
| 2019-09-30 | $24 |
| 2019-06-30 | $27 |
| 2019-03-31 | $19 |
| 2018-12-31 | $23 |
| 2018-09-30 | $19 |
| 2018-06-30 | $17 |
| 2018-03-31 | $15 |
| 2017-12-31 | $11 |
| 2017-09-30 | $10 |
| 2017-06-30 | $10 |
| 2017-03-31 | $8 |
| 2016-12-31 | $-0 |
| 2016-09-30 | $5 |
| 2016-06-30 | $5 |
| 2016-03-31 | $3 |
| 2015-12-31 | |
| 2015-09-30 | $-0 |
| 2014-12-31 | |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.276B | $1.886B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $98.015B | 12.16 |
| Cencora (COR) | United States | $48.948B | 18.05 |
| DiDi Global (DIDIY) | China | $23.622B | 0.00 |
| ICON (ICLR) | Ireland | $17.731B | 15.79 |
| Natera (NTRA) | United States | $16.587B | 0.00 |
| Viatris (VTRS) | United States | $15.469B | 4.76 |
| Avantor (AVTR) | United States | $15.375B | 23.05 |
| Revvity (RVTY) | United States | $14.905B | 25.89 |
| BioMerieux (BMXMF) | France | $13.087B | 0.00 |
| CochLear (CHEOY) | Australia | $12.590B | 0.00 |
| Solventum (SOLV) | United States | $12.509B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.014B | 21.28 |
| Doximity (DOCS) | United States | $10.815B | 64.01 |
| HealthEquity (HQY) | United States | $8.629B | 46.83 |
| Sonic Healthcare (SKHHY) | Australia | $8.542B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $7.043B | 32.79 |
| Life Times (LTH) | United States | $5.170B | 34.22 |
| Sotera Health (SHC) | United States | $4.557B | 24.38 |
| Organon (OGN) | United States | $4.131B | 4.17 |
| Surgery Partners (SGRY) | United States | $3.859B | 42.76 |
| BrightSpring Health Services (BTSG) | United States | $3.408B | 72.48 |
| PACS (PACS) | United States | $3.251B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.620B | 0.00 |
| Concentras Parent (CON) | United States | $2.500B | 0.00 |
| Ardent Health Partners (ARDT) | United States | $2.337B | 0.00 |
| Premier (PINC) | United States | $2.292B | 11.44 |
| GeneDx Holdings (WGS) | United States | $2.137B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.856B | 48.90 |
| Teladoc Health (TDOC) | United States | $1.589B | 0.00 |
| Progyny (PGNY) | United States | $1.499B | 26.37 |
| Pediatrix Medical (MD) | United States | $1.353B | 13.24 |
| Establishment Labs Holdings (ESTA) | $1.292B | 0.00 | |
| CareDx (CDNA) | United States | $1.268B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.104B | 7.49 |
| Embecta (EMBC) | United States | $0.897B | 5.98 |
| InnovAge Holding (INNV) | United States | $0.813B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| Agilon Health (AGL) | United States | $0.757B | 0.00 |
| SBC Medicals (SBC) | United States | $0.706B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.514B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.469B | 0.00 |
| DocGo (DCGO) | United States | $0.409B | 15.38 |
| Enhabit (EHAB) | United States | $0.397B | 34.30 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.373B | 0.00 |
| LifeMD (LFMD) | United States | $0.252B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.225B | 0.00 |
| ModivCare (MODV) | United States | $0.221B | 12.05 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| Biodesix (BDSX) | United States | $0.199B | 0.00 |
| Nutex Health (NUTX) | United States | $0.160B | 0.00 |
| MultiPlan (MPLN) | United States | $0.137B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.129B | 0.00 |
| So-Young (SY) | China | $0.089B | 21.63 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.055B | 0.00 |
| OncoCyte (OCX) | United States | $0.048B | 0.00 |
| NeueHealth (NEUE) | United States | $0.042B | 1.11 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.030B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.028B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.028B | 0.00 |
| Oncology Institute (TOI) | United States | $0.020B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |